Patent Assignment
Reel/Frame 067482/0330
Change of Name
Recorded: 2024-05-21
Pages: 4
Assignor
LIPOZYT MARKER UG
Executed: 2024-05-21
Assignee
LIPOCYTE BIOMED GMBH
ERBRICHTERWEG 7A, BREMEN, 28357, GERMANY
Covered Property
(1)
Use of the Il-6 Gene Expression Level for Classification of a Subject in Risk Groups in the Prognosis or Diagnosis of Type Ii Diabetes Mellitus
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.